Yesterday
Should weight-loss drugs be given to children?
A battle over how to treat childhood obesity is brewing between two groups who each believe their approach has young people’s best interests at heart.
This Month
Big pharma steps up push for taxpayer-funded weight-loss drugs
Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be less costly than later treatment.
January
Fit is better than thin, says latest research on longevity
The researchers reviewed 20 studies involving nearly 400,000 middle-aged or older people from multiple nations, about 30 per cent of them women.
Cancer rates among the young are increasing. Is food to blame?
Early onset cancer cases have increased by a staggering 79 per cent in the last 30 years, alarming figures show.
No, the budget is not out of control
Readers’ letters on Australia’s economy, sport and climate change, wage theft, populism, emissions reporting, AustralianSuper’s performance and beer bellies.
Price must be right to put obesity drug on the PBS
It is vital the gatekeepers of the scheme hold the line on the cost benefits of blockbuster drugs.
The real reason men get belly fat (and how to get rid of it)
Research suggests it’s more harmful to be a man who is overweight than a woman who is carrying extra pounds.
It’s not just obesity. Drugs like Ozempic will change the world
It is early days yet, but glp-1 receptor agonists have all the makings of one of the most successful classes of drugs in history.
December 2024
Will Ozempic crush the junk-food business?
Developers inventing products for big food companies are trying to work out how to sell convenience food to those who suddenly crave fresh fruit.
September 2024
The doctor-turned-CEO aiming to beat Ozempic
Adam Steensberg leads Zealand Pharma, a Danish drug maker whose stock has risen by more than 800 per cent since he took over in 2022.
ASX hopeful Evolt 360 reveals plans to cash in on Ozempic boom
The founders of body scanning company are hoping to list on the stock market before Christmas, backed by investors including Regal, Soul Patts and Perennial.
Novo Nordisk says new obesity pill reduces weight by 13.1pc
It says experimental pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.
July 2024
The five best exercises to beat burnout and stress
Knowing what type of exercise to focus on when needed is key to allowing the stress chemicals to move through you more effectively.
Are you overweight or obese? Depends on where you carry your fat
European experts have developed a new framework to modernise the staging, diagnosis and management of obesity.
June 2024
Why that surprise weight gain might be an Ozempic baby
There is mounting evidence that weigh-loss drugs such as Ozempic are delivering baby-sized surprises.
I tried the ‘Tesla’ of fasting diets. Here’s what happened
Valter Longo’s books about the benefits of abstaining from food have been bestsellers around the world, but the science to support his ideas is not conclusive.
How to dementia-proof your life in your 40s
Research shows that this decade plays a crucial role in predicting your future brain health – and nobody knows why.
Three ways to start exercising outdoors – and stick to it
Hate the gym? There are clear benefits to spending time in nature, so here’s how to start exercising outside and stick with it.
May 2024
Do you have ‘portion distortion’? Here’s how big your dinner should be
Our appetites and waistlines have been growing at an alarming rate over the past few decades. Here’s how you can bring your dinners back under control.
Morgan Spurlock, ‘Super Size Me’ documentary director, dies at 53
The filmmaker’s career imploded after he acknowledged past incidents of sexual assault and harassment. The cause of his death was cancer.